Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of cardiovascular and neurological disorders
3.2.1.2 Technological advancements in IVD diagnostics
3.2.1.3 Rising adoption of point of care testing
3.2.1.4 Increasing focus on research for the development of novel diagnostics
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory scenario
3.2.2.2 High development costs
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Reagents, kits, & consumables
5.4 Software & services
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Immunoassays
6.2.1 Enzyme-linked immunosorbent assay (ELISA)
6.2.2 Chemiluminescence immunoassay (CLIA)
6.2.3 Fluorescence immunoassay (FIA)
6.2.4 Other immunoassays
6.3 Molecular diagnostics
6.3.1 Polymerase chain reaction (PCR)
6.3.2 Hybridization
6.3.3 Sequencing
6.3.4 Isothermal nucleic acid amplification technology (INAAT)
6.3.5 Microarrays
6.3.6 Other molecular diagnostics
6.4 Hematology
6.5 Other technologies
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals & clinics
7.3 Diagnostic laboratories
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Becton, Dickinson and Company
9.3 bioMerieux S.A.
9.4 Bio-Rad Laboratories, Inc.
9.5 Danaher Corporation
9.6 DiaSorin S.p.A.
9.7 F. Hoffmann-La Roche Ltd.
9.8 QIAGEN N.V.
9.9 Siemens Healthineers AG
9.10 Sysmex Corporation
9.11 Thermo Fisher Scientific Inc.
